Fertility and Sterility
Volume 85, Issue 5 , Pages 1307-1318 , May 2006

Aromatase inhibitors: the next generation of therapeutics for endometriosis?

  • Erkut Attar, M.D.

      Affiliations

    • Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Istanbul University, Istanbul Medical School, Istanbul, Turkey
    • ,
  • Serdar E. Bulun, M.D.

      Affiliations

    • Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Serdar E. Bulun, M.D., Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, 303 East Superior Street, 4-123, Chicago, Illinois 60611 (FAX: 312-503-0095).

Received 29 April 2005 ,Revised 7 September 2005 ,Accepted 7 September 2005.

References 

  1. Houston DE , Noller KL , Melton LJ , Selwyn BJ . The epidemiology of pelvic endometriosis . Clin Obstet Gynecol . 1988;31:787–800
  2. Cramer DW , Missmer SA . The epidemiology of endometriosis . Ann NY Acad Sci . 2002;955:11–22
  3. Sensky TE , Liu DT . Endometriosis (associations with menorrhagia, infertility and oral contraceptives) . Int J Gynaecol Obstet . 1980;17:573–576
  4. Eskenazi B , Warner ML . Epidemiology of endometriosis . Obstet Gynecol Clin North Am . 1997;24:235–258
  5. Hadfield R , Mardon H , Barlow D , Kennedy S . Delay in the diagnosis of endometriosis (a survey of women from the USA and the UK) . Hum Reprod . 1996;11:878–880
  6. Zeitoun KM , Bulun SE . Aromatase (a key molecule in the pathophysiology of endometriosis and a therapeutic target) . Fertil Steril . 1999;72:961–969
  7. Simpson ER , Mahendroo MS , Means GD , Kilgore MW , Hinshelwood MM , Graham-Lorence S , et al.   Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis . Endocr Rev . 1994;15:342–355
  8. Simpson ER , Clyne C , Rubin G , Boon WC , Robertson K , Britt K , et al.   Aromatase–a brief overview . Annu Rev Physiol . 2002;64:93–127
  9. Brodie A , Long B . Aromatase inhibition and inactivation . Clin Cancer Res . 2001;7:4343s–4349s
  10. Bulun SE , Zeitoun K , Takayama K , Noble L , Michael D , Simpson E , et al.   Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis . Endocr Relat Cancer . 1999;6:293–301
  11. Sebastian S , Takayama K , Shozu M , Bulun S . Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue . Mol Endocrinol . 2002;16:2243–2254
  12. Simpson ER , Clyne C , Rubin G , Boon WC , Robertson K , Britt K , et al.   Aromatase—a brief overview . Annu Rev Physiol . 2002;64:93–127
  13. Simpson ER , Zhao Y , Agarwal VR , Michael MD , Bulun SE , Hinshelwood MM , et al.   Aromatase expression in health and disease . 1997;52:185–214
  14. Simpson ER , Mahendroo MS , Means GD , Kilgore MW , Corbin CJ , Mendelson CR . Tissue-specific regulation of aromatase cytochrome P450 expression . In:  Schenkmon JB ,  Greim H editor. Handbook of experimental pharmacology cytochrome P450 . Berlin: Springer-Verlag; 1993;p. 611–625
  15. Simpson ER , Graham-Lorence S , Corbin CJ , Merrill JC , Means GD , Mahendroo MS , et al.   Regulation of expression of the gene encoding aromatase cytochrome P450 . In:  Nunez J ,  Dumont JE editor. Hormones and cell regulation . London, UK: Libby; 1992;p. 49–55
  16. Noble LS , Takayama K , Putman JM , Johns DA , Hinshelwood MM , Agarwal VR , et al.   Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells . J Clin Endocrinol Metab . 1997;82:600–606
  17. Zeitoun K , Takayama K , Michael MD , Bulun SE . Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element . Mol Endocrinol . 1999;13:239–253
  18. Noble LS , Simpson ER , Johns A , Bulun SE . Aromatase expression in endometriosis . J Clin Endocrinol Metab . 1996;81:174–179
  19. Wu M , Wang C , Lin C , Chen L , Chang W , Tsai S . Distinct regulation of cyclooxygenase-2 by interleukin-1{beta} in normal and endometriotic stromal cells . J Clin Endocrinol Metab . 2005;90(1):286–295
  20. Ota H , Igarashi S , Sasaki M , Tanaka T . Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis . Hum Reprod . 2001;16:561–566
  21. Bulun SE , Yang S , Fang Z , Gurates B , Tamura M , Zhou J , et al.   Role of aromatase in endometrial disease . J Steroid Biochem Mol Biol . 2001;79:19–25
  22. Tsai SJ , Wu MH , Lin CC , Sun HS , Chan HM . Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells . J Clin Endocrinol Metab . 2001;86:5765–5773
  23. Goss PE , Strasser K . Aromatase inhibitors in the treatment and prevention of breast cancer . J Clin Oncol . 2001;19:881–894
  24. Buzdar A , Howell A . Advances in aromatase inhibition (clinical efficacy and tolerability in the treatment of breast cancer) . Clin Cancer Res . 2001;7:2620–2635
  25. Buzdar AU , Robertson JF , Eiermann W , Nabholtz JM . An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane . Cancer . 2002;95:2006–2016
  26. de Jong PC , van de Ven J , Nortier HW , Maitimu-Smeele I , Donker TH , Thijssen JH , et al.   Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole . Cancer Res . 1997;57:2109–2111
  27. Santen RJ , Misbin RI . Aminoglutethimide (review of pharmacology and clinical use) . Pharmacotherapy . 1981;1:95–120
  28. Santen RJ . Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma (a review) . Breast Cancer Res Treat . 1981;1:183–202
  29. Santen RJ , Santner S , Davis B , Veldhuis J , Samojlik E , Ruby E . Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma . J Clin Endocrinol Metab . 1978;47:1257–1265
  30. Santen RJ , Lipton A , Harvey H , Wells SA . Use of aminoglutethimide and hydrocortisone as a “medical adrenalectomy” for treatment of breast carcinoma . Prog Clin Cancer . 1982;8:245–265
  31. Santen RJ . Clinical use of aromatase inhibitors (current data and future perspectives) . J Enzym Inhib . 1990;4:79–99
  32. Santen RJ , Manni A , Harvey H , Redmond C . Endocrine treatment of breast cancer in women . Endocr Rev . 1990;11:221–265
  33. Santen RJ . Recent progress in development of aromatase inhibitors . J Steroid Biochem Mol Biol . 1990;37:1029–1035
  34. Dowsett M . Endocrine treatment of advanced breast cancer . Acta Oncol . 1996;35(Suppl 5):68–72
  35. Dowsett M , Lonning PE . Anastrozole–a new generation in aromatase inhibition (clinical pharmacology) . Oncology . 1997;54(Suppl 2):11–14
  36. Buzdar AU , Jonat W , Howell A , Plourde PV . ARIMIDEX (a potent and selective aromatase inhibitor for the treatment of advanced breast cancer) . J Steroid Biochem Mol Biol . 1997;61:145–149
  37. Buzdar AU , Plourde PV , Hortobagyi GN . Aromatase inhibitors in metastatic breast cancer . Semin Oncol . 1996;23:28–32
  38. Buzdar AU , Hortobagyi G . Update on endocrine therapy for breast cancer . Clin Cancer Res . 1998;4:527–534
  39. Dombernowsky P , Smith I , Falkson G , Leonard R , Panasci L , Bellmunt J , et al.   Letrozole, a new oral aromatase inhibitor for advanced breast cancer (double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate) . J Clin Oncol . 1998;16:453–461
  40. Gershanovich M , Chaudri HA , Campos D , Lurie H , Bonaventura A , Jeffrey M , et al.  Letrozole International Trial Group (AR/BC3)   Letrozole, a new oral aromatase inhibitor (randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer) . Ann Oncol . 1998;9:639–645
  41. Demers LM , Lipton A , Harvey HA , Kambic KB , Grossberg H , Brady C , et al.   The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer . J Steroid Biochem Mol Biol . 1993;44:687–691
  42. Plourde PV , Dyroff M , Dukes M . Arimidex (a potent and selective fourth-generation aromatase inhibitor) . Breast Cancer Res Treat . 1994;30:103–111
  43. Dowsett M , Jones A , Johnston SR , Jacobs S , Trunet P , Smith IE . In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer . Clin Cancer Res . 1995;1:1511–1515
  44. Kleeberg UR , Dowsett M , Carrion RP , Dodwell DJ , Vorobiof DA , Aparicio LA , et al.   A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer . Oncology . 1997;54(Suppl 2):19–22
  45. Scott LJ , Wiseman LR . Exemestane . Drugs . 1999;58:675–680
  46. Amsterdam LL , Gentry W , Jobanputra S , Wolf M , Rubin SD , Bulun SE . Anastrazole and oral oral contraceptives (a novel treatment for endometriosis) . Fertil Steril . 2005;84(2):300–304
  47. Buzdar AU . The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial (an update) . Clin Breast Cancer . 2004;5(Suppl 1):S6–S12
  48. Senkus-Konefka E , Konefka T , Jassem J . The effects of tamoxifen on the female genital tract . Cancer Treat Rev . 2004;30:291–301
  49. Ailawadi RK , Jobanputra S , Kataria M , Gurates B , Bulun SE . Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate (a pilot study) . Fertil Steril . 2004;81:290–296
  50. Soysal S , Soysal M , Ozer S , Gul N , Gezgin T . The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis (a prospective randomized trial) . Hum Reprod . 2004;19:160–167
  51. Sebastian S , Bulun SE . A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project . J Clin Endocrinol Metab . 2001;86:4600–4602
  52. Moudgal NR , Shetty G , Selvaraj N , Bhatnagar AS . Use of a specific aromatase inhibitor for determining whether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo development . J Reprod Fertil Suppl . 1996;50:69–81
  53. Santen RJ , Samojlik E , Wells SA . Resistance of the ovary to blockade of aromatization with aminoglutethimide . J Clin Endocrinol Metab . 1980;51:473–477
  54. Harris AL , Dowsett M , Jeffcoate SL , McKinna JA , Morgan M , Smith IE . Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer . J Clin Endocrinol Metab . 1982;55:718–722
  55. Wander HE , Blossey HC , Nagel GA . Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer . Eur J Cancer Clin Oncol . 1986;22:1371–1374
  56. Stein RC , Dowsett M , Hedley A , Davenport J , Gazet JC , Ford HT , et al.   Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione . Cancer Chemother Pharmacol . 1990;26:75–78
  57. Wouters W , De Coster R , Krekels M , van Dun J , Beerens D , Haelterman C , et al.   R 76713, a new specific non-steroidal aromatase inhibitor . J Steroid Biochem . 1989;32:781–788
  58. Stein RC , Dowsett M , Hedley A , Gazet JC , Ford HT , Coombes RC . The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer . Br J Cancer . 1990;62:679–683
  59. Mitwally MF , Casper RF . Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate . Fertil Steril . 2001;75:305–309
  60. Cortinez A , De Carvalho I , Vantman D , Gabler F , Iniguez G , Vega M . Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients . Fertil Steril . 2005;83:110–115
  61. Fisher SA , Reid RL , Van Vugt DA , Casper RF . A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women . Fertil Steril . 2002;78:280–285
  62. Mitwally MF , Casper RF . Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders . Fertil Steril . 2002;77:776–780
  63. Mitwally MF , Casper RF . Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation . J Soc Gynecol Investig . 2004;11:406–415
  64. Goswami SK , Das T , Chattopadhyay R , Sawhney V , Kumar J , Chaudhury K , et al.   A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response (a preliminary report) . Hum Reprod . 2004;19:2031–2035
  65. Forward DP , Cheung KL , Jackson L , Robertson JF . Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer . Br J Cancer . 2004;90:590–594
  66. Vercellini P , Trespidi L , Colombo A . A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis . Fertil Steril . 1993;60:75–79
  67. Waller KG , Shaw RW . Gonadotropin-releasing hormone analogues for the treatment of endometriosis (long-term follow-up) . Fertil Steril . 1993;59:511–515
  68. Vercellini P , Trespidi L , DeGiorgi O , Cortesi I , Parazzini F , Crosignani PG . Endometriosis and pelvic pain. Relation to disease stage and localization . Fertil Steril . 1996;65:299–304
  69. Kauppila A . Changing concepts of medical treatment of endometriosis . Acta Obstet Gynecol Scand . 1993;72:324–336
  70. Vercellini P , Fedele L , Bianchi S , Candiani GB . Pelvic denervation for chronic pain associated with endometriosis (fact or fancy?) . Am J Obstet Gynecol . 1991;165:745–749
  71. Wilson ML , Farquhar CM , Sinclair OJ , Johnson NP . Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea . Cochrane Database Syst Rev . 2000;(2):CD001896
  72. Gambone JC , Mittman BS , Munro MG , Scialli AR , Winkel CA . Consensus statement for the management of chronic pelvic pain and endometriosis (proceedings of an expert-panel consensus process) . Fertil Steril . 2002;78:961–972
  73. Olive DL , Pritts EA . The treatment of endometriosis (a review of the evidence) . Ann NY Acad Sci . 2002;955:360–372
  74. Pierce SJ , Gazvani MR , Farquharson RG . Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis (a randomized trial with a 6-year follow-up) . Fertil Steril . 2000;74:964–968
  75. Martin DC , Ling FW . Endometriosis and pain . Clin Obstet Gynecol . 1999;42:664–686
  76. Vercellini P , De Giorgi O , Pisacreta A , Pesole AP , Vicentini S , Crosignani PG . Surgical management of endometriosis . Baillieres Best Pract Res Clin Obstet Gynaecol . 2000;14:501–523
  77. Shippen ER , West WJ . Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor . Fertil Steril . 2004;81:1395–1398
  78. Takayama K , Zeitoun K , Gunby RT , Sasano H , Carr BR , Bulun SE . Treatment of severe postmenopausal endometriosis with an aromatase inhibitor . Fertil Steril . 1998;69:709–713
  79. Razzi S , Fava A , Sartini A , De Simone S , Cobellis L , Petraglia F . Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman . Br J Obstet Gynaecol . 2004;111:182–184
  80. Biberoglu KO , Behrman SJ . Dosage aspects of danazol therapy in endometriosis (short-term and long-term effectiveness) . Am J Obstet Gynecol . 1981;139:645–654
  81. Bulun SE , Imir G , Utsunomiya H , Thung S , Gurates B , Tamura M , et al.   Aromatase in endometriosis and uterine leiomyomata . J Steroid Biochem Mol Biol . 2005;95(1–5):57–62

 Supported by National Institutes of Health (Bethesda, MD) grant HD 36891 and a grant from Friends of Prentice, Chicago, Illinois.

PII: S0015-0282(06)00228-7

doi: 10.1016/j.fertnstert.2005.09.064

Fertility and Sterility
Volume 85, Issue 5 , Pages 1307-1318 , May 2006

Article Tools

* Image Usage & Resolution